Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Pericardial Effusion”

14 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 14 results

Large-scale testing (Phase 3)Study completedNCT00347412
What this trial is testing

Study of NOV-002 in Combination With Chemotherapy to Treat Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Cellectar Biosciences, Inc. 903
Not applicableEnded earlyNCT04472468
What this trial is testing

Primary Percutaneous Pericardiotomy for Malignant Pericardial Effusion (PMAP)

Who this might be right for
Pericardial Effusion Malignant
Chinese University of Hong Kong 50
Testing effectiveness (Phase 2)Study completedNCT00126581
What this trial is testing

Erlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III-IV Non-small Cell Lung Cancer

Who this might be right for
Lung AdenocarcinomaLung Adenosquamous CarcinomaMalignant Pericardial Effusion+4 more
National Cancer Institute (NCI) 188
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT00431015
What this trial is testing

Phase I/II Safety Study of IPI-504 in Relapsed/Refractory Stage IIIb, or Stage IV Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung Cancer
Infinity Pharmaceuticals, Inc. 88
Testing effectiveness (Phase 2)WithdrawnNCT00005645
What this trial is testing

ILX-295501 in Treating Patients With Stage III or Stage IV Ovarian Cancer That Has Not Responded to Previous Treatment

Who this might be right for
Fallopian Tube CancerMetastatic CancerOvarian Cancer+1 more
Genzyme, a Sanofi Company
Testing effectiveness (Phase 2)Ended earlyNCT00791154
What this trial is testing

QUILT-2.013: First-Line Treatment for Extensive Stage Small Cell Lung Cancer

Who this might be right for
Lung CancerSmall Cell Lung CancerSolid Tumors+1 more
NantCell, Inc. 213
Post-approval studies (Phase 4)UnknownNCT05077111
What this trial is testing

A Comparative Study Between Regional Anesthesia in Thoracoscopes and the Conventional General Anesthesia

Who this might be right for
Pleural Effusion, MalignantPleural MesotheliomaPleural Empyema+9 more
Mohamed Reda Ashour 40
Large-scale testing (Phase 3)Study completedNCT00132613
What this trial is testing

Trial of Drainage With or Without Bleomycin Instillation for Malignant Pericardial Effusion

Who this might be right for
Malignant Pericardial Effusion
Japan Clinical Oncology Group 80
Not applicableUnknownNCT01665495
What this trial is testing

Drainage or Pericardiocentesis (DROP) Alone for Recurrent Non-malignant Pericardial Effusions Requiring Intervention

Who this might be right for
Pericardial Effusion
Maria Vittoria Hospital 122
Testing effectiveness (Phase 2)Study completedNCT02054052
What this trial is testing

Intrapleural Bevacizumab Injection for Malignant Effusion in Lung Cancer

Who this might be right for
Non-small Cell Lung CancerMalignant Pleural Effusion
Haihong Yang, MD, Pricipal investigator 22
Early research (Phase 1)Study completedNCT00004074
What this trial is testing

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

Who this might be right for
Advanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Study completedNCT00508144
What this trial is testing

Single Agent Alimta in Poor Performance Status in Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 64
Not applicableEnded earlyNCT02132884
What this trial is testing

Genetic Sequencing-Informed Targeted Therapy in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer

Who this might be right for
Malignant Pericardial EffusionMalignant Pleural EffusionRecurrent Non-small Cell Lung Cancer+2 more
Fox Chase Cancer Center 1